These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31670914)

  • 21. Lower Serum miR-145 Predicts Poor Prognosis in Patients with Acute Myeloid Leukemia.
    Shi Q; Xing G; Qi M; Xing Y
    Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-181a-3p as a Diagnostic and Prognostic Biomarker for Acute Myeloid Leukemia.
    Qiang P; Pan Q; Fang C; Fozza C; Song K; Dai Y; Chang W; Chen W; Yao W; Zhu W; Liu X; Ma X
    Mediterr J Hematol Infect Dis; 2020; 12(1):e2020012. PubMed ID: 32180907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum miR-133 as a novel biomarker for predicting treatment response and survival in acute myeloid leukemia.
    Zheng ZZ; Ma YP; Wu RH; Rong G; Li C; Li GX; Ren FG; Xu LJ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):777-783. PubMed ID: 32016982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTCF boundary remodels chromatin domain and drives aberrant
    Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
    Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
    Schwind S; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Whitman SP; Hickey C; Becker H; Metzeler KH; Paschka P; Baldus CD; Liu S; Garzon R; Powell BL; Kolitz JE; Carroll AJ; Caligiuri MA; Larson RA; Marcucci G; Bloomfield CD
    J Clin Oncol; 2010 Dec; 28(36):5257-64. PubMed ID: 21079133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
    Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
    Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.
    Lin X; Wang Z; Zhang R; Feng W
    Clin Transl Oncol; 2015 May; 17(5):358-64. PubMed ID: 25301405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
    Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
    Seyyedi SS; Soleimani M; Yaghmaie M; Ajami M; Ajami M; Pourbeyranvand S; Alimoghaddam K; Akrami SM
    Tumour Biol; 2016 Apr; 37(4):4841-7. PubMed ID: 26526573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid Leukemia.
    Xu L; Wang A; Guan H
    Cancer Biother Radiopharm; 2024 Sep; 39(7):492-501. PubMed ID: 38949985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
    Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
    Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia.
    Yu G; Yin Z; He H; Zheng Z; Chai Y; Xuan L; Lin R; Wang Q; Li J; Xu D
    J Clin Lab Anal; 2020 Mar; 34(3):e23096. PubMed ID: 31691380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM].
    Hua JY; Feng Y; Pang Y; Zhou XH; Xu B; Yan MX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):347-51. PubMed ID: 27150990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia.
    Zha J; Lai Q; Deng M; Shi P; Zhao H; Chen Q; Wu H; Xu B
    Stem Cell Rev Rep; 2020 Dec; 16(6):1280-1291. PubMed ID: 33057942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.
    Huang X; Schwind S; Santhanam R; Eisfeld AK; Chiang CL; Lankenau M; Yu B; Hoellerbauer P; Jin Y; Tarighat SS; Khalife J; Walker A; Perrotti D; Bloomfield CD; Wang H; Lee RJ; Lee LJ; Marcucci G
    Oncotarget; 2016 Sep; 7(37):59273-59286. PubMed ID: 27517749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
    Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
    J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
    Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
    Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
    Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.
    Starkova J; Zamostna B; Mejstrikova E; Krejci R; Drabkin HA; Trka J
    Pediatr Blood Cancer; 2010 Dec; 55(6):1072-82. PubMed ID: 20672366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.